Riskpilot← Back to searchSign inGet full accessIntegrameda AB
ABActiveOrg 5593551277Björnflokevägen 173Computer consultancy and computer facilities management activities · NACE 6220Est. 20210 employees
Revenue 2025
SEK 1,4M
+82% vs 2024
EBITDA margin
67.2%
+105% vs 2024
Equity ratio
56.4%
Financial strength
Net profit 2025
SEK 557K
+105% vs 2024
| Revenue | SEK 1,4M | +82% |
| EBITDA | SEK 938K | +105% |
| Net profit | SEK 557K | +105% |
| Total assets | SEK 1,4M | +33% |
| Equity | SEK 792K | +82% |
| Employees | 0 | — |
Legal name
Integrameda AB
Org number
5593551277
Legal form
Aktiebolag
NACE code
6220 · Computer consultancy and computer facilities management activities
Founded
20 december 2021
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva datakonsultverksamhet med syfte att utveckla kvalitetsledningssystem inom medicinteknik jämte därmed förenlig verksamhet samt handel med värdepapper jämte därmed förenlig verksamhet och förvärv och förvaltning av såväl fast som lös egendom samt därmed förenlig verksamhet. Med lös egendom menas till exempel nyttjanderätter, immateriella rättigheter eller lokal, fastighet klassad som lös egendom som är relevanta för och främjar utvecklingen av bolaget och dess verksamhet.
Address
Björnflokevägen 173
Email
andersextrakonto@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 238 | 150 | 768 | 1 396 |
| Staff expenses | — | — | — | — |
| EBITDA | 155 | 80 | 458 | 938 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 155 | 80 | 458 | 938 |
| Net financials | −0 | 0 | 0 | 1 |
| Profit before tax | 116 | 59 | 344 | 703 |
| Tax | −24 | −13 | −71 | −146 |
| Net profit | 92 | 46 | 272 | 557 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 442 | 573 | 1 055 | 1 403 |
| Equity | 117 | 163 | 435 | 792 |
| Long-term debt | — | — | — | — |
| Short-term debt | 286 | 351 | 445 | 200 |
| Total debt | 286 | 351 | 445 | 200 |
EBITDA margin
67.2%
This company
15.8%
Market median
+325% vs market
20222025
Equity ratio
56.4%
This company
38.2%
Market median
+48% vs market
20222025
Return on equity
70.3%
This company
18.4%
Market median
+282% vs market
20222025
Net profit margin
39.9%
This company
8.1%
Market median
+393% vs market
20222025
Asset turnover
0.99×
This company
1.12×
Market median
+12% vs market
20222025
Debt / equity
0.77×
This company
0.62×
Market median
+24% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-12-20 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Integrameda AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Olof Bergström | Chairman | 0 companies |
| Adam Viktor Olof Bergström | Deputy Board Member | 0 companies |
| Irene Mariana Sellgren | Board of Directors | 0 companies |